ChristophPohlMD
Radiology • Lewisberry, PAInterventional Neuroradiology, Vascular & Interventional Radiology
Physician
Are you Dr. Pohl?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 75 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6290 Lowther Road
Lewisberry, PA 17339Phone+1 717-932-5200Fax+1 717-932-3095
Summary
- Dr. Christoph Pohl, MD is a board certified radiologist in Lewisberry, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, Delaware, and Massachusetts. He is affiliated with UPMC Harrisburg, Penn State Health Holy Spirit Medical Center, and UPMC Carlisle.
Education & Training
Tufts Medical CenterFellowship, Vascular and Interventional Radiology, 1994 - 1995
Atlantic Health System/Morristown Medical CenterResidency, Radiology-Diagnostic, 1990 - 1994
HCA Healthcare Chippenham & Johnston-Willis HospitalsResidency, Family Medicine, 1988 - 1990
Inova Fairfax Medical CampusInternship, Family Medicine, 1987 - 1988
Virginia Commonwealth University School of MedicineClass of 1987
Certifications & Licensure
MA State Medical License 1994 - 2026
PA State Medical License 1997 - 2026
DE State Medical License 1996 - 2023
VA State Medical License 1989 - 2016
NJ State Medical License 1992 - 2005- American Board of Radiology Interventional Radiology and Diagnostic Radiology
Publications & Presentations
PubMed
- 25 citationsMRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.Kerstin Bendfeldt, Bernd Taschler, Laura Gaetano, Philip Madoerin, Pascal Kuster
Brain Imaging and Behavior. 2019-10-01 - 26 citationsNew insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis - Implications from the prospective multicenter VADERA II study.Matthias Englbrecht, Rieke Alten, Martin Aringer, Christoph Baerwald, Harald Burkhardt
Plos One. 2019-05-28 - 22 citationsPredictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b:Douglas S. Goodin, Anthony T. Reder, Anthony Traboulsee, David Kb Li, Dawn Langdon
Multiple Sclerosis. 2019-05-01
Professional Memberships
- Member
